Hookipa Biotech GmbH
Records under this name other than the patents Hookipa Biotech GmbH holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,669,315 | HPV Vaccines now held by AstraZeneca Ireland Limited In force · High confidence | In force | High confidence | |
| US 11,407,790 | HPV Vaccines now held by AstraZeneca Ireland Limited In force · High confidence | In force | High confidence | |
| US 11,214,598 | Vaccines Against Hepatitis B Virus now held by Gilead Sciences, Inc. In force · High confidence | In force | High confidence | |
| US 11,266,727 | Arenavirus Particles as Cancer Vaccines now held by AstraZeneca Ireland Limited In force · High confidence | In force | High confidence | |
| US 10,111,945 | CMV Vaccines Lapsed on the fee record Ended Oct 30, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 30, 2026 | Low confidence |
| 16/302,086 | Tri-Segmented Pichinde Viruses as Vaccine Vectors now held by Gilead Sciences, Inc. Abandoned Abandoned Sep 28, 2022 | Abandoned | Abandoned Sep 28, 2022 | |
| 16/347,501 | Replication-Deficient Arenavirus Particles and Tri-Segmented Arenavirus Particles as Cancer Vaccines now held by AstraZeneca Ireland Limited Abandoned Abandoned Jul 10, 2024 | Abandoned | Abandoned Jul 10, 2024 | |
| 16/500,648 | Arenavirus Particles to Treat Solid Tumors now held by AstraZeneca Ireland Limited Abandoned Abandoned Jul 9, 2024 | Abandoned | Abandoned Jul 9, 2024 | |
| 17/535,121 | Vaccines Against Hepatitis B Virus now held by Gilead Sciences, Inc. Abandoned Abandoned Sep 12, 2025 | Abandoned | Abandoned Sep 12, 2025 | |
| 17/582,682 | Arenavirus Particles as Cancer Vaccines now held by AstraZeneca Ireland Limited Abandoned Abandoned Feb 7, 2026 | Abandoned | Abandoned Feb 7, 2026 |